Flupentixol/melitracen
From Wikipedia, the free encyclopedia
| Combination of | |
|---|---|
| Flupentixol | Typical antipsychotic |
| Melitracen | Tricyclic antidepressant |
| Clinical data | |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| ATC code | N06CA02 |
 (what is this?) (verify) | |
Flupentixol/melitracen (trade name Deanxit, Placida, Franxit, Anxidreg) is a combination of two psychoactive agents which has antidepressant properties. It is designed for short term usage only. It is produced by Lundbeck.[1]
It's banned in India, Denmark, US, the UK, Ireland, Canada, Japan, and Australia.[2]
References
- ↑ Sweetman, Sean C., ed. (2009). "Preparations". Martindale: The complete drug reference (36th ed.). London: Pharmaceutical Press. p. 2607. ISBN 978-0-85369-840-1.
- ↑ Bhaumik S. India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen. BMJ. 2013;347(jul05 2):f4366. doi:10.1136/bmj.f4366
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.